eli lilly tirzepatide fda approval Lilly's gained in December 2024 for treating moderate-to-severe obstructive sleep apnea in adults with obesity, after Phase III trials showed a 20% average weight loss and a roughly FDA approves new weight loss

If you frequently struggle with adherence, discuss this openly with your GP or diabetes specialist nurse, as they may suggest strategies tailored to your lifestyle or consider whether alternative treatment regimens might be more suitable for your circumstances

When standard lab tests return "normal" despite life-altering symptoms, it is easy to feel dismissed by the medical system

A useful framing from a clinical perspective: NAD+ helps patients feel better faster, while Sermorelin helps them function better overall

The soup recipes (Recipes 22 to 24) and Greek yogurt bowl (Recipe 31) are particularly useful during the adjustment period